EQUITY METHOD INVESTMENTS (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
Equity method investments, disclosures | |||
Investment in equity method investees in excess of the proportionate share of net assets | $ 1,671us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity | ||
Summarized financial information - Income statement | |||
Equity income (loss) - net | 769us-gaap_IncomeLossFromEquityMethodInvestments | 602us-gaap_IncomeLossFromEquityMethodInvestments | 819us-gaap_IncomeLossFromEquityMethodInvestments |
Summarized financial information - Balance sheet | |||
Equity Method Investments | 9,947us-gaap_EquityMethodInvestments | 10,393us-gaap_EquityMethodInvestments | |
Other Equity Method Investees [Member] | |||
Summarized financial information - Income statement | |||
Net operating revenues |
52,627us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
53,038us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
47,087us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Cost of goods sold |
31,810us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCostOfSales / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
32,377us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCostOfSales / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
28,821us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCostOfSales / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Gross profit |
20,817us-gaap_EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
20,661us-gaap_EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
18,266us-gaap_EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Operating income |
4,489ko_EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
4,380ko_EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
4,605ko_EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Consolidated net income |
2,440ko_EquityMethodInvestmentSummarizedFinancialInformationProfitLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
2,364ko_EquityMethodInvestmentSummarizedFinancialInformationProfitLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
2,993ko_EquityMethodInvestmentSummarizedFinancialInformationProfitLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Less: Net income attributable to noncontrolling interests |
74ko_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLossAttributableToNonControllingInterest / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
62ko_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLossAttributableToNonControllingInterest / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
89ko_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLossAttributableToNonControllingInterest / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Net income attributable to common shareowners |
2,366us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
2,302us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
2,904us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
Summarized financial information - Balance sheet | |||
Current Assets |
16,184us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
19,229us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Noncurrent assets |
40,080us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
40,427us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Total assets |
56,264us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
59,656us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Current liabilities |
12,477us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
14,386us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Noncurrent liabilities |
16,657us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
17,779us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Total liabilities |
29,134us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
32,165us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Equity attributable to shareowners of investees |
26,363us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
26,668us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Equity attributable to noncontrolling interests |
767us-gaap_EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
823us-gaap_EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Total Equity |
27,130us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
27,491us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Equity Method Investments |
9,947us-gaap_EquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
10,393us-gaap_EquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_OtherEquityMethodInvesteesMember |
|
Other Equity Method Investments | |||
Summary of significant transactions with equity method investees | |||
Concentrate, syrup and finished product sales |
10,063us-gaap_RevenueFromRelatedParties / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
9,178us-gaap_RevenueFromRelatedParties / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
7,082us-gaap_RevenueFromRelatedParties / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
Purchases of finished product |
381us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
415us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
392us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
Marketing payments made by us |
$ 1,605ko_RelatedPartyTransactionMarketingPaymentsDirectlyToRelatedParty / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
$ 1,807ko_RelatedPartyTransactionMarketingPaymentsDirectlyToRelatedParty / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
$ 1,587ko_RelatedPartyTransactionMarketingPaymentsDirectlyToRelatedParty / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_MostlylocatedoutsideoftheUSAMember |
Coca-Cola FEMSA | |||
Equity method investments, disclosures | |||
Ownership interest in Equity investee (as a percent) |
28.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_CocaColaFemsaMember |
||
Coca-Cola Hellenic | |||
Equity method investments, disclosures | |||
Ownership interest in Equity investee (as a percent) |
23.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_CocaColaHellenicMember |
||
Coca-Cola Amatil | |||
Equity method investments, disclosures | |||
Ownership interest in Equity investee (as a percent) |
29.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = ko_CocaColaAmatilMember |
X | ||||||||||
- Definition
This item represents the disclosure of net income (loss) attributable to noncontrolling interests for unconsolidated subsidiaries and 50 percent-or-less owned entities accounted for using the equity method of accounting. No definition available.
|
X | ||||||||||
- Definition
This item represents the disclosure of operating income (loss) for unconsolidated subsidiaries and 50 percent-or-less owned entities accounted for using the equity method of accounting. No definition available.
|
X | ||||||||||
- Definition
This item represents the disclosure of net income (loss) including the portion attributable to noncontrolling interests for unconsolidated subsidiaries and 50 percent-or-less owned entities accounted for using the equity method of accounting. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Marketing payments made by the reporting entity to a related party. No definition available.
|
X | ||||||||||
- Definition
Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of assets reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of the cost of sales reported by an equity method investment of the entity. No definition available.
|
X | ||||||||||
- Definition
The amount of current assets reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of current liabilities reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of equity, including noncontrolling interest, reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of equity, excluding noncontrolling interest, attributable to the equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of gross profit (loss) reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The amount of liabilities reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of equity attributable to noncontrolling interests of an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of noncurrent assets reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of noncurrent liabilities reported by an equity method investment of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of revenue from sale of goods and services reduced by sales returns, allowances, and discounts reported by an equity method investment of the entity. No definition available.
|
X | ||||||||||
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|